{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:12:38Z","timestamp":1778638358462,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Canadian Network on Hepatitis C","award":["(HPC-178912)"],"award-info":[{"award-number":["(HPC-178912)"]}]},{"DOI":"10.13039\/501100000105","name":"York University","doi-asserted-by":"publisher","award":["Junior Faculty\/Minor Research Grant"],"award-info":[{"award-number":["Junior Faculty\/Minor Research Grant"]}],"id":[{"id":"10.13039\/501100000105","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13198-6","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:36:27Z","timestamp":1775061387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C self-testing and self-collection among people with experience in the Canadian carceral system: a qualitative study"],"prefix":"10.1186","volume":"26","author":[{"given":"Tamara","family":"Barnett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kody","family":"Muncaster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Gemma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chance","family":"Cordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew B.","family":"Mendlowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia. J.","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"13198_CR1","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. 2024."},{"key":"13198_CR2","unstructured":"World Health Organization. Updated recommendations on HCV simplified service delivery and HCV diagnostics: Policy brief. 2022. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240052697."},{"issue":"7","key":"13198_CR3","doi-asserted-by":"publisher","first-page":"e26136","DOI":"10.1002\/jia2.26136","volume":"26","author":"JK Rockstroh","year":"2023","unstructured":"Rockstroh JK, Swan T, Chang J, Elamouri F, Lloyd AR. The path to hepatitis C elimination: who are we leaving behind and why? J Int AIDS Soc. 2023;26(7):e26136.","journal-title":"J Int AIDS Soc"},{"key":"13198_CR4","unstructured":"World Health Organization. New recommendation on hepatitis C virus testing and treatment for people at on going risk of infection: Policy brief. 2023. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/366869\/9789240071872-eng.pdf."},{"issue":"12","key":"13198_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","volume":"18","author":"J Stone","year":"2018","unstructured":"Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(12):1397\u2013409.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"13198_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S2468-1253(20)30365-4","volume":"6","author":"MJ Akiyama","year":"2021","unstructured":"Akiyama MJ, Kronfli N, Cabezas J, Sheehan Y, Thurairajah PH, Lines R, et al. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework. Lancet Gastroenterol Hepatol. 2021;6(5):391\u2013400.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"13198_CR7","unstructured":"Public Health Agency of Canada. Viral hepatitis estimates among key populations in Canada, 2021\u20132025 March 16. 2026. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/viral-hepatitis-estimates-key-populations-2021.html."},{"issue":"4","key":"13198_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3138\/canlivj.2019-0007","volume":"2","author":"N Kronfli","year":"2019","unstructured":"Kronfli N, Buxton JA, Jennings L, Kouyoumdjian F, Wong A. Hepatitis C virus (HCV) care in Canadian correctional facilities: Where are we and where do we need to be? Can Liver J. 2019;2(4):171\u201383.","journal-title":"Can Liver J"},{"key":"13198_CR9","unstructured":"World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030 Geneva: World Health Organization. 2022. Available from: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/6b18ac34-f56a-466e-9660-b5653cb52ef0\/content."},{"key":"13198_CR10","unstructured":"The Canadian Network on Hepatitis C. Blueprint to Inform Hepatitis C Elimination Efforts in Canada. 2019."},{"key":"13198_CR11","unstructured":"World Health Organization Global health sector strategy on viral hepatitis. 2016\u20132021 Geneva 2016 [cited 2025 November 3]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06."},{"key":"13198_CR12","unstructured":"World Health Organization. Recommendations and Guidance on Hepatitis C Virus Self-Testing. 2021:1\u201332."},{"key":"13198_CR13","doi-asserted-by":"crossref","unstructured":"Walker JG, Easterbrook P, Fajardo E, Ivanova E, Jamil MS, Johnson C, et al. Web Annex F. Cost effectivness of hepatitis C virus self-testing. In: Reomendations and guidance on heaptitis C virus self-testing. 2021.","DOI":"10.1101\/2022.08.09.22278580"},{"issue":"5","key":"13198_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2468-1253(21)00471-4","volume":"7","author":"EB Cunningham","year":"2022","unstructured":"Cunningham EB, Wheeler A, Hajarizadeh B, French CE, Roche R, Marshall AD, et al. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(5):426\u201345.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"13198_CR15","doi-asserted-by":"crossref","unstructured":"Cunningham E, Wheeler A, Hajarizadeh B, French C, Roche R, Roth M, et al. Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis. Int J Drug Policy. 2025.","DOI":"10.1016\/j.drugpo.2025.105082"},{"issue":"3","key":"13198_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3343\/alm.2013.33.3.184","volume":"33","author":"YJ Cha","year":"2013","unstructured":"Cha YJ, Park Q, Kang ES, Yoo BC, Park KU, Kim JW, et al. Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann Lab Med. 2013;33(3):184\u20139.","journal-title":"Ann Lab Med"},{"issue":"7","key":"13198_CR17","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.cgh.2020.07.058","volume":"19","author":"D Smookler","year":"2021","unstructured":"Smookler D, Vanderhoff A, Biondi MJ, Valencia J, Ryan P, Karkada J, et al. Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNA. Clin Gastroenterol Hepatol. 2021;19(7):1451\u2013e84.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"13198_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12879-024-08989-8","volume":"24","author":"N Carrington","year":"2024","unstructured":"Carrington N, Conway A, Grebely J, Starr M, Catlett B, Stevens A, et al. Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot. BMC Infect Dis. 2024;24(1):137.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13198_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-7517-10-7","volume":"10","author":"M Harris","year":"2013","unstructured":"Harris M, Rhodes T. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduct J. 2013;10(1):7.","journal-title":"Harm Reduct J"},{"issue":"6","key":"13198_CR20","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/infdis\/jiac049","volume":"226","author":"B Catlett","year":"2022","unstructured":"Catlett B, Hajarizadeh B, Cunningham E, Wolfson-Stofko B, Wheeler A, Khandaker-Hussain B, et al. Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review. J Infect Dis. 2022;226(6):1005\u201321.","journal-title":"J Infect Dis"},{"issue":"6","key":"13198_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S2468-1253(25)00050-0","volume":"10","author":"G Fontaine","year":"2025","unstructured":"Fontaine G, Taylor N, Bruneau J, Kronfli N, Greenaway C, Biondi MJ, et al. The urgent need for implementation science to achieve hepatitis C elimination. Lancet Gastroenterol Hepatol. 2025;10(6):498\u2013502.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"13198_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12879-022-07484-2","volume":"22","author":"E Fajardo","year":"2022","unstructured":"Fajardo E, Watson V, Kumwenda M, Usharidze D, Gogochashvili S, Kakhaberi D, et al. Usability and acceptability of oral-based HCV self-testing among key populations: a mixed-methods evaluation in Tbilisi, Georgia. BMC Infect Dis. 2022;22(1):510.","journal-title":"BMC Infect Dis"},{"key":"13198_CR23","unstructured":"Paing MY, Naing Y, Aung K. Examining the role of oral fluid HCV self-testing in enhancing hepatitis C screening acceptance rates. a systematic review. 2024."},{"key":"13198_CR24","doi-asserted-by":"crossref","unstructured":"Thorne S. Interpretive description: qualitative research for applied practice. 2025.","DOI":"10.4324\/9781003503538"},{"key":"13198_CR25","unstructured":"World Health Organization. Self-testing implementation toolkit for HIV, hepatitis and sexually transmitted infections. 2024."},{"issue":"6","key":"13198_CR26","first-page":"2045","volume":"26","author":"R Maietta","year":"2021","unstructured":"Maietta R, Mihas P, Swartout K, Petruzzelli J, Hamilton AB. Sort and Sift, Think and Shift: Let the Data Be Your Guide An Applied Approach to Working With, Learning From, and Privileging Qualitative Data. Qualitative Rep. 2021;26(6):2045\u201360.","journal-title":"Qualitative Rep"},{"issue":"12","key":"13198_CR27","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/v17121590","volume":"17","author":"M Selfridge","year":"2025","unstructured":"Selfridge M, Barnett T, Munro L, Card K, Nishimura S, Beaumont A, et al. Innovative Nurse-Led Community Health Centre\u2013Corrections Partnership for Hepatitis C Testing and Treatment in Victoria, British Columbia. Viruses. 2025;17(12):1590.","journal-title":"Viruses"},{"issue":"1","key":"13198_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-11-1","volume":"11","author":"JA Barocas","year":"2014","unstructured":"Barocas JA, Brennan MB, Hull SJ, Stokes S, Fangman JJ, Westergaard RP. Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study. Harm Reduct J. 2014;11(1):1.","journal-title":"Harm Reduct J"},{"issue":"1","key":"13198_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13722-021-00260-8","volume":"16","author":"JI Tsui","year":"2021","unstructured":"Tsui JI, Barry MP, Austin EJ, Sweek EW, Tung E, Hansen RN, et al. Treat my whole person, not just my condition\u2019: qualitative explorations of hepatitis C care delivery preferences among people who inject drugs. Addict Sci Clin Pract. 2021;16(1):52.","journal-title":"Addict Sci Clin Pract"},{"key":"13198_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.drugpo.2017.08.004","volume":"50","author":"C Henderson","year":"2017","unstructured":"Henderson C, Madden A, Kelsall J. Beyond the willing & the waiting\u2019 \u2014 The role of peer-based approaches in hepatitis C diagnosis & treatment. Int J Drug Policy. 2017;50:111\u20135.","journal-title":"Int J Drug Policy"},{"key":"13198_CR31","doi-asserted-by":"crossref","unstructured":"Papaluca T, Craigie A, McDonald L, Edwards A, Winter R, Hoang A, et al. Care navigation increases initiation of hepatitis C treatment after release from prison in a prospective randomized controlled trial: the C-LINK study. Open Forum Infect Dis. 2022;9(8).","DOI":"10.1093\/ofid\/ofac350"},{"key":"13198_CR32","doi-asserted-by":"crossref","unstructured":"Nguyen LT, Nguyen VTT, Le Ai KA, Truong MB, Tran TTM, Jamil MS, et al. Acceptability and usability of HCV self-testing in high risk populations in Vietnam. Diagnostics (Basel). 2021;11(2).","DOI":"10.3390\/diagnostics11020377"},{"key":"13198_CR33","doi-asserted-by":"publisher","first-page":"102921","DOI":"10.1016\/j.drugpo.2020.102921","volume":"85","author":"N Kronfli","year":"2020","unstructured":"Kronfli N, Dussault C, Chalifoux S, Kavoukian H, Klein MB, Cox J. A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada. Int J Drug Policy. 2020;85:102921.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"13198_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12879-018-3185-7","volume":"18","author":"A Guise","year":"2018","unstructured":"Guise A, Witzel TC, Mandal S, Sabin C, Rhodes T, Nardone A, et al. A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK. BMC Infect Dis. 2018;18(1):281.","journal-title":"BMC Infect Dis"},{"key":"13198_CR35","doi-asserted-by":"publisher","first-page":"104919","DOI":"10.1016\/j.drugpo.2025.104919","volume":"143","author":"J Demant","year":"2025","unstructured":"Demant J, Nilsson SS, Krohn-Dehli L, \u00d8vrehus A, Mygind LH, Madsen LW, et al. Peer-delivered mail-order self-collection and linkage to treatment for hepatitis C virus infection among users of a harm reduction service in Denmark. Int J Drug Policy. 2025;143:104919.","journal-title":"Int J Drug Policy"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13198-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13198-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13198-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:53:38Z","timestamp":1778637218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13198-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13198"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13198-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and approved by York University Institutional Review Board (certificate e2023-222). Informed consent was obtained from all participants prior to their involvement in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TB declares speaking and consulting fees from AbbVie and Gilead. MJB declares receiving research funding from AbbVie, Gilead, and Cepheid, and speaking and consulting fees from AbbVie and Gilead. No other authors declared a competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"939"}}